After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Amylyx Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $19.14 and fluctuated between $19.22 as its day high and $17.94 as its day low. The current market capitalization of Amylyx Pharmaceuticals Inc is $1.30B. A total of 1.84 million shares were traded on the day, compared to an average of 1.23M shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, AMLX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 22 BUYs and 33 SELLs from insiders. Insiders purchased 488,387 shares during that period but sold 2,994,838.
In the most recent transaction, Mazzariello Gina sold 2,838 shares of AMLX for 18.76 per share on Feb 23. After the transaction, the Chief Legal Officer now owns 46,245 company shares. In a previous transaction on Jan 09, Klee Justin B. sold 5,841 shares at 16.33 per share. AMLX shares that Co-Chief Executive Officer owns now total 2,836,776.
Among the insiders who sold shares, Cohen Joshua B disposed of 5,841 shares on Jan 09 at a per-share price of $16.33. This resulted in the Co-Chief Executive Officer holding 2,900,470 shares of AMLX after the transaction. In another insider transaction, Yeramian Patrick D sold 2,812 shares at $16.33 per share on Jan 09. Company shares held by the Chief Medical Officer now total 205,605.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AMLX has a high of $38.32 and a low of $11.82.
As of this writing, AMLX has an earnings estimate of $0.15 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.3 per share and a lower estimate of $0.06. The company reported an EPS of $0.3 in the last quarter, which was -30.20% lower than expectations of $0.43.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMLX’s latest balance sheet shows that the firm has $96.12M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $17.40M in liabilities at the time. Its Book Value Per Share was $6.40, while its Total Shareholder’s Equity was -$151.17M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMLX is Buy with a score of 5.00.
